SAVARA INC's ticker is SVRA and the CUSIP is 805111101. A total of 68 filers reported holding SAVARA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $44,362 | +64.3% | 11,736 | -8.5% | 0.00% | – |
| Q1 2021 | $27,000 | +125.0% | 12,833 | +20.3% | 0.00% | – |
| Q4 2020 | $12,000 | -70.0% | 10,669 | -29.4% | 0.00% | – |
| Q3 2019 | $40,000 | +21.2% | 15,106 | +7.4% | 0.00% | – |
| Q2 2019 | $33,000 | -70.3% | 14,064 | -6.5% | 0.00% | -100.0% |
| Q1 2019 | $111,000 | -1.8% | 15,048 | +0.8% | 0.00% | 0.0% |
| Q4 2018 | $113,000 | -43.2% | 14,926 | -16.2% | 0.00% | 0.0% |
| Q3 2018 | $199,000 | +8.7% | 17,816 | +10.3% | 0.00% | 0.0% |
| Q2 2018 | $183,000 | +40.8% | 16,154 | +14.6% | 0.00% | 0.0% |
| Q1 2018 | $130,000 | -46.7% | 14,102 | -14.2% | 0.00% | -50.0% |
| Q4 2017 | $244,000 | – | 16,433 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 5,128,593 | $5,898,000 | 0.37% |
| FARALLON CAPITAL MANAGEMENT LLC | 4,452,086 | $5,120,000 | 0.03% |
| Woodline Partners LP | 374,904 | $431,000 | 0.01% |
| Gyon Technologies Capital Management, LP | 19,679 | $23,000 | 0.01% |
| AXA S.A. | 1,895,554 | $2,180,000 | 0.01% |
| WEXFORD CAPITAL LP | 31,253 | $36,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 192,100 | $221,000 | 0.01% |
| Capital Advantage, Inc. | 14,658 | $18,000 | 0.01% |
| RGT Wealth Advisors, LLC | 10,000 | $12,000 | 0.00% |
| Crewe Advisors LLC | 3,910 | $4,000 | 0.00% |